The effect of percutaneous electrical nerve stimulation on the respiratory outcomes of patients with Covid-19 with moderate pulmonary involvement: A clinical trial

Shahroud University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新: 2022年8月29日

适应症

试验速览

暂无简介。

•Confirmation of Covid-19 diagnosis based on PCR test results or CT Scan findings (Ground Glass view) by physician
•Age over 18 and under 70 years
•Use the same treatment protocol for patients
•Existence of moderate pulmonary involvement (SpO2 between 90 to 93% and pulmonary involvement less than 50%) and the patient being in the second phase of Covid-19 disease according to the guideline of the Ministry of Health

•Drug addiction
•Cigarette addiction
•Advanced metastatic cancer
•Congestive heart failure (grades 3 and 4)
•Kidney failure requires dialysis
•History of mechanical ventilation before intervention
•Existence of cardiac pacemaker
•Cardiac conduction disorders
•History of allergies and skin sensitivities in the area of ??the electrodes
•The presence of a skin lesion in the area where the electrodes are placed
•Hospitalized patients with other clinical manifestations of Covid-19 and no pulmonary involvement
•Continuous use of bronchodilators
•Having liver failure
•Moderate to severe scoliosis
•Obesity (BMI above 35)
•Psychological illnesses lead to lack of patient cooperation
•Cerebrovascular disorders
•Having COPD
•Having uncontrolled diabetes
•Inability and prohibition to be in a semi-sitting position for any reason

发起方